Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of Nevirapine and Methadone in HIV-1 Infected Adults
NCT00273988Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 2002
- Primary completion
- Oct 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of nevirapine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Boehringer Ingelheim. Primary endpoint: Clearance of methadone at steady state at Day 21. Started Apr 2002; status: completed.
02
Drugs
nevirapine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00273988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00273988.